AVROBIO Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
TECX$21.89+6.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(6,808) | $(24,957) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | 878 | 2,530 |
| Depreciation and amortization expense | — | 328 |
| Non-cash interest expense | — | 80 |
| Non-cash lease expense | 322 | 592 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | 884 | 2,187 |
| Accounts payable | 216 | 207 |
| Current and non-current operating lease liabilities | (654) | (600) |
| Accrued expenses and other current liabilities | (2,407) | (651) |
| Net cash used in operating activities | (7,569) | (20,284) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | — | (8) |
| Net cash used in investing activities | — | (8) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 26 | 42 |
| Proceeds from issuance of ESPP shares | 4 | 13 |
| Net cash provided by financing activities | 30 | 55 |
| Net decrease in cash, cash equivalents and restricted cash | (7,539) | (20,237) |
| Cash, cash equivalents and restricted cash at beginning of period | 98,703 | 92,846 |
| Cash, cash equivalents and restricted cash at end of period | $91,164 | $72,609 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Interest paid | $— | $463 |
| Lease liability arising from obtaining right-of-use assets | — | 2,392 |
| Reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets: | ||
| Cash and cash equivalents, end of period | $90,481 | $72,326 |
| Restricted cash | 683 | 283 |
| Cash, cash equivalents and restricted cash, end of period | $91,164 | $72,609 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.